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Failure to eliminate the carrier state of Anaplasma marginale by using long-acting
injectable oxytetracycline
Abstract
Thirty-four Anaplasma marginale seropositive cows from a herd of 236 were allocated to treatments: 5
animals served as untreated controls, and 29 animals were treated with three injections of long-acting
oxytetracycline at three-day intervals. Fourteen days after initiation of treatment, 100% of control cows
and 89% of treated cows were found to have Anaplasma marginale present. Seventyfour days after
initiation of treatment, 100% of control cows and 86% of treated cows were found to have Anaplasma
marginale present. Use of injectable long-acting oxytetracycline was not effective in eliminating the
carrier state of Anaplasma marginale from infected animals.
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Cattlemen’s Day 2004

FAILURE TO ELIMINATE THE CARRIER STATE OF ANAPLASMA MARGINALE
BY USING LONG-ACTING INJECTABLE OXYTETRACYCLINE
L. C. Hollis, D. Gnad1, T. Marston, D. Llewellyn, and G. Palmer2

was to use ELISA and PCR diagnostic methodologies to determine the efficacy of three
injections of long-acting injectable oxytetracycline.

Summary
Thirty-four Anaplasma marginale seropositive cows from a herd of 236 were allocated to treatments: 5 animals served as untreated controls, and 29 animals were treated
with three injections of long-acting oxytetracycline at three-day intervals. Fourteen days
after initiation of treatment, 100% of control
cows and 89% of treated cows were found to
have Anaplasma marginale present. Seventyfour days after initiation of treatment, 100% of
control cows and 86% of treated cows were
found to have Anaplasma marginale present.
Use of injectable long-acting oxytetracycline
was not effective in eliminating the carrier
state of Anaplasma marginale from infected
animals.

Experimental Procedures
A commercial cow herd of 236 animals
was screened for antibodies to Anaplasma
marginale by using the card-agglutination test;
75 animals tested positive. Sixty-three of these
75 animals were found to be positive for
Anaplasma marginale when confirmatory testing with both ELISA and PCR technology was
conducted 20 days before the start of the study
(day -20). Twenty-nine of the 63 positive
animals were reserved for another study, and
34 animals were included in this study. At the
start of the study (day 0), 5 of the 34 animals
were randomly allocated to a control group,
and the remaining 29 were allocated to the
oxytetracycline treatment group. On the basis
of an average estimated weight of 1200 lb,
animals in the oxytetracycline-treated group
received 60 mL of a long-acting, injectable
oxytetracycline product containing 200
mg/mL oxytetracycline solution. All injections
were given subcutaneously in the neck, with
the 60 mL dose being distributed among four
injection sites on one side of the neck on each
treatment day. Treatment was repeated at
three-day intervals for a total of three treatments per animal. Blood samples were taken
from all animals 14 days after initiation of

Introduction
Treatment with long-acting injectable
oxytetracycline has long been recommended
as one means of clearing the carrier state of
Anaplasma marginale from infected cattle.
Older diagnostic methods, such as the complement-fixation test and card-agglutination
test have indicated the success of such treatment. Newer diagnostic methods, such as enzyme-linked immunosorbent assay (ELISA)
and polymerase chain reaction (PCR) have
enhanced the ability to assess the presence of
antibodies to those organisms or the organisms themselves. The objective of this study
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was completed during the months of December and January. Study animals were not
treated with any antimicrobial product by injection or feed additive after initial screening
or during the study period. Precautions were
taken to prevent the likelihood that needleborne transmission of Anaplasma marginale
would occur during springtime vaccinations.
Day 14 blood samples were drawn before the
start of the biting fly season, when Anaplasma
marginale transmission could occur. Day 74
blood samples were drawn after the biting fly
season was under way.

treatment (day 14), and again 60 days later
(day 74). Blood samples were forwarded for
PCR testing on day 14 and 74 and for ELISA
testing on day 74.
Results and Discussion
On day 14, 5 of 5 control animals (100%)
and 25 of 28 oxytetracycline-treated animals
(89%) were PCR positive for the presence of
Anaplasma marginale organisms (Table 1).
The sample from one oxytetracycline-treated
cow was lost from the samples submitted for
PCR testing on day 14. ELISA testing was
not conducted on samples collected on day 14
because this testing method measures the serological status of animals, which was not expected to change that rapidly after death of
Anaplasma marginale organisms. On day 74,
2 of 5 control animals (40%) and 16 of 29
oxytetracycline-treated animals (55%) were
ELISA positive for antibodies to Anaplasma
marginale, whereas 5 of 5 control animals
(100%) and 25 of 29 oxytetracycline-treated
animals (86%) were PCR positive for the
presence of Anaplasma marginale organisms.

Repeated injections of long-acting oxytetracycline were not effective in eliminating the
carrier state of Anaplasma marginale from
infected animals (Table 1). PCR testing was
able to detect the presence of Anaplasma marginale organisms even when ELISA testing
did not detect serological evidence of their
presence (Table 1).
The declining ELISA results from day -20
to day 74 in both control and oxytetracyclinetreated animals (Table 1) were unexpected and
suggested a degree of non-treatment-related
recovery or reversion to non-seropositive
status in both groups. However, the PCR results indicated that Anaplasma marginale organisms were present on both day 14 and day
74. If treatment with three injections of longacting oxytetracyline had been successful in
eliminating the carrier state of Anaplasma
marginale, PCR test results were expected to
have been negative on both test dates.

All study animals had access to a freechoice mineral mix containing 4.25 g chlortetracycline/lb mix during the period of mid-May
through mid-October, before initial serological
screening. Consumption of the mineral mix
during that period was approximately 0.25 lb
cow daily. Precautions were not taken to preclude the needle-borne transmission of
Anaplasma marginale during late-October
herd vaccinations. Initial serological screening
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Table 1. Lack of Efficacy of Treatment with Long-Acting Oxytetracycline as Indicated by
Number and Percentage of Animals Still Positive for Anaplasma marginale on the Basis of
ELISA and PCR Testing on Each Study Day
Control

Study Day
−20

ELISA

PCR

ELISA

PCR

Positive (%)

Positive (%)

Positive (%)

Positive (%)

5/5 (100)

5/5 (100)

29/29 (100)

29/29 (100)

14
74

Long-Acting Oxytetracycline

5/5 (100)
2/5 (40)

5/5 (100)
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25/28 (89)
16/29 (55)

25/29 (86)

